Top story The Shocking Truth: Up to 20% of MS Diagnoses May Be Incorrect – What Every Patient Needs to Know
The “Don’t Die” Guy Faces a New Battle: Bryan Johnson Reveals He’s Living with a Serious Autoimmune Disease
AstraZeneca's Ultomiris Poised for Accelerated Approval in IgA Nephropathy After Striking Trial Results
Kyverna's KYV-101: A Glimmer of Hope for Lupus Nephritis Patients with Early, Deep Responses, Yet Caution Remains
Takeda's Zasocitinib Shows Promising Phase III Results for Psoriasis, Signaling a Potential Breakthrough
A New Horizon for Celiac Patients? Quantum Biopharma's Breakthrough Trial Results Published in a Prestigious Peer-Reviewed Journal